Neumora Therapeutics NMRA
NASDAQ NMRA
$0.46 -0.01 (-2.56%)
As of: Nov 12, 2026 · 1:56 PM EST

Neumora Therapeutics (NMRA) Sales of Property, Plant and Equipment (2025 - 2026)

Updated

Neumora Therapeutics (NMRA) recorded Sales of Property, Plant and Equipment of $71,000 in Q1 2026, up 51.1% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Sales of Property, Plant and Equipment (2025 - 2026) Analysis & Trends

For FY2025, Neumora Therapeutics reported Sales of Property, Plant and Equipment of $218,000.

  • Quarterly Sales of Property, Plant and Equipment has ranged from $47,000 in Q4 2025 to $87,000 in Q3 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $47,000 (Q4 2025), $87,000 (Q3 2025) and $84,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Neumora Therapeutics 88.31 Mn -529.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 71,000.00
Dec 31, 2025 47,000.00
Sep 30, 2025 87,000.00
Jun 30, 2025 84,000.00
API Access

Neumora Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=NMRA&period=max&api_key=YOUR_API_KEY